Faculty

Gregory T. Armstrong, MD, MSCE
Epidemiology and Cancer Control
St. Jude Children’s Research Hospital
Memphis, TN

R. Frank Cornell, MD, MS
Clinical Director, Plasma Cell Disorders
Assistant Professor, Vanderbilt University
Nashville, TN

Christopher R. Ellis, MD
Director LAA Closure Program
Associate Professor, Vanderbilt University
Nashville, TN

Douglas B. Johnson, MD
Director, Melanoma Program
Assistant Professor, Vanderbilt University
Nashville, TN

Philip Lammers, MD
Hematology and Oncology
Baptist Cancer Center
Memphis, TN

Ingrid Mayer, MD, MSCI
Co-Leader, VICC Breast Cancer
Research Program
Professor of Medicine, Vanderbilt University
Nashville, TN

Frank McGrew, MD
Director of Clinical Research
Stern Cardiovascular
Memphis, TN

Glenn Roma, PharmD
Baptist Cancer Center
Memphis, TN

Rachel P. Rosovsky, MD, MPH
Director of Thrombosis Research
Massachusetts General Hospital
Boston, MA

Holger Salazar, MD, FACC
Cardiology
Stern Cardiovascular
Memphis, TN

Jonathan Schoenecker, MD, PhD
Assistant Professor, Bone Biology
Vanderbilt University
Nashville, TN

David Slosky, MD
Assistant Professor, Cardiovascular
Vanderbilt University
Nashville, TN

Arie Szatkowski, MD
Co-Director Cardio-Oncology
Quality Director, Stern Cardiovascular
Memphis, TN

Alyssa Throckmorton, MD, FACS
Breast Surgeon, Baptist Medical Group
Clinical Assistant Professor,
University of TN Health Science Center
Memphis, TN

Saliendra Vasireddy, MD
Hematology and Oncology
Baptist Cancer Center
Memphis, TN

Deborah E. Wallace, MSN, FNP-BC, AOCNP
Hematology and Oncology
Vanderbilt University
Nashville, TN

Angela Wortham, MD
Radiation Oncology
Baptist Cancer Center
Memphis, TN

Faculty Disclosure

It is the policy of Baptist Memorial Health Care Corporation (BMHCC) to promote balance, independence, objectivity, and scientific rigor in all educational activities; to require disclosure of relevant financial relationships from individuals engaged in content development or planning of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity. Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.